Literature DB >> 11685249

A novel, specific interaction involving the Csk SH3 domain and its natural ligand.

R Ghose1, A Shekhtman, M J Goger, H Ji, D Cowburn.   

Abstract

C-terminal Src kinase (Csk) takes part in a highly specific, high affinity interaction via its Src homology 3 (SH3) domain with the proline-enriched tyrosine phosphatase PEP in hematopoietic cells. The solution structure of the Csk-SH3 domain in complex with a 25-residue peptide from the Pro/Glu/Ser/Thr-rich (PEST) domain of PEP reveals the basis for this specific peptide recognition motif involving an SH3 domain. Three residues, Ala 40, Thr 42 and Lys 43, in the SH3 domain of Csk specifically recognize two hydrophobic residues, Ile 625 and Val 626, in the proline-rich sequence of the PEST domain of PEP. These two residues are C-terminal to the conventional proline-rich SH3 domain recognition sequence of PEP. This interaction is required in addition to the classic polyproline helix (PPII) recognition by the Csk-SH3 domain for the association between Csk and PEP in vivo. NMR relaxation analysis suggests that Csk-SH3 has different dynamic properties in the various subsites important for peptide recognition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685249     DOI: 10.1038/nsb1101-998

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  50 in total

1.  Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly.

Authors:  Olli Aitio; Maarit Hellman; Arunas Kazlauskas; Didier F Vingadassalom; John M Leong; Kalle Saksela; Perttu Permi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Distinct peptide binding specificities of Src homology 3 (SH3) protein domains can be determined by modulation of local energetics across the binding interface.

Authors:  Maryna Gorelik; Alan R Davidson
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

3.  Structural characterization of Lyn-SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity.

Authors:  Finn Bauer; Kristian Schweimer; Heike Meiselbach; Silke Hoffmann; Paul Rösch; Heinrich Sticht
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

Review 4.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

Authors:  Shawn S-C Li
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

5.  NMR determination that an extended BH3 motif of pro-apoptotic BID is specifically bound to BCL-XL.

Authors:  Hong Ji; Alex Shekhtman; Ranajeet Ghose; James M McDonnell; David Cowburn
Journal:  Magn Reson Chem       Date:  2006-07       Impact factor: 2.447

6.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

7.  NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition.

Authors:  Munia Mukherjee; Kaushik Dutta; Mark A White; David Cowburn; Robert O Fox
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

8.  Yeast display evolution of a kinetically efficient 13-amino acid substrate for lipoic acid ligase.

Authors:  Sujiet Puthenveetil; Daniel S Liu; Katharine A White; Samuel Thompson; Alice Y Ting
Journal:  J Am Chem Soc       Date:  2009-11-18       Impact factor: 15.419

9.  Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.

Authors:  Keiichiro Kami; Ryu Takeya; Hideki Sumimoto; Daisuke Kohda
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

10.  Blood pressure homeostasis is maintained by a P311-TGF-β axis.

Authors:  Kameswara Rao Badri; Ming Yue; Oscar A Carretero; Sree Latha Aramgam; Jun Cao; Stephen Sharkady; Gene H Kim; Gregory A Taylor; Kenneth L Byron; Lucia Schuger
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.